Osteopenia Cissus quadrangularis Osteopenia Postmenopause Bone marker
Conditions
Interventions
Cissus quadrangularis (400 mg/tab) 1 tab oral twice a day,
morning and evening,No any medication
Sham Comparator Drug,Sham Comparator No treatment
Cissus quadrangularis,Control
Sponsors
Faculty of Medicine, Ramathibodi hospital
Eligibility
Sex/Gender
Female
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Postmenopausal women no menstruation at least one year with osteopenia diagnosed by Dual energy X ray absorptiometry DEXA T score bone mineral density BMD at lumbar spine or hip less than or equal to t 1 0 Willing to enroll in the study and sign consent form
Exclusion criteria
Exclusion criteria: abnormal glomerular filtration rate GFR abnormal liver function test LFT Previous treated with bisphosphanate selective estrogen receptor modulator SERM steroid hormonal replacement therapy HRT Osteopenia fcaused from other causes scleroderma rheumatoid Participant decline to enroll in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum bone marker 3 months serum P1NP, serum betacrosslap | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver and renal function test 3 months Serum alanine transaminase, serum aspartate transaminase, BUN, cr | — |
Countries
Thailand
Contacts
Public ContactOlarik Musigavong
unaffiliated
Outcome results
None listed